Effectiveness of sequential treatment of advanced or metastatic renal cell carcinoma (mRCC). Outcome data from the clinical RCC Registry.

Goebell, P.J., Müller, L., Lück, A., Overkamp, F., Vogt, M., Marschner, N., 2013.

Onkologie 36 (suppl. 7)(V40), 8. doi:10.1159/000356365

Studie: TNK; Indikation: Nierenzellkarzinom; Jahr: 2013; Veranstaltung: DGHO; Journal: Onkologie

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com